Prasugrel-–-Advanced-Antiplatelet-Therapy-for-Card
Prasugrel
| Product dosage: 10 mg | |||
|---|---|---|---|
| Package (num) | Per pill | Price | Buy |
| 30 | 1.80 $ | 54.00 $ (0%) | 🛒 Add to cart |
| 60 | 1.65 $ | 108.00 $ 99.00 $ (8%) | 🛒 Add to cart |
| 90 | 1.59 $ | 162.00 $ 143.00 $ (12%) | 🛒 Add to cart |
| 120 | 1.49 $ | 216.00 $ 179.00 $ (17%) | 🛒 Add to cart |
| 180 | 1.44 $ | 324.00 $ 260.00 $ (20%) | 🛒 Add to cart |
| 360 | 1.28 $
Best per pill | 648.00 $ 462.00 $ (29%) | 🛒 Add to cart |
Synonyms | |||
Prasugrel is a potent P2Y12 adenosine diphosphate (ADP) receptor antagonist used to prevent thrombotic cardiovascular events in patients with acute coronary syndrome (ACS) undergoing percutaneous coronary intervention (PCI). As a third-generation thienopyridine, it offers superior platelet inhibition compared to older agents, reducing the risk of stent thrombosis, myocardial infarction (MI), and stroke.
Key Technical Specifications
- Active Ingredient: Prasugrel hydrochloride
- Dosage Forms: 5 mg, 10 mg film-coated tablets
- Mechanism of Action: Irreversible P2Y12 receptor inhibition
- Bioavailability: ≥79% (rapid absorption)
- Peak Plasma Concentration: ~30 minutes
- Half-Life: ~7 hours (active metabolite)
- Metabolism: Hepatic (CYP3A4, CYP2B6)
- Excretion: Renal (68%), fecal (27%)
- Storage Conditions: Below 30°C (86°F), protect from moisture
Advantages of Prasugrel
✅ Superior Antiplatelet Efficacy – Faster and more consistent platelet inhibition than clopidogrel.
✅ Reduced Thrombotic Events – Proven to lower rates of stent thrombosis and recurrent MI.
✅ Optimal for High-Risk Patients – Recommended for diabetic patients and those with prior stent thrombosis.
✅ Minimal Drug-Drug Interactions – Less affected by CYP2C19 polymorphisms compared to clopidogrel.
✅ Convenient Dosing – Once-daily administration improves compliance.
Clinical Performance & Ratings
| Parameter | Rating (★/5) | Remarks |
|---|---|---|
| Efficacy | ★★★★★ | Superior to clopidogrel in TRITON-TIMI 38 trial |
| Safety | ★★★★☆ | Higher bleeding risk vs. clopidogrel (managed with proper dosing) |
| Patient Adherence | ★★★★★ | Simple dosing regimen |
| Cost-Effectiveness | ★★★★☆ | Justified by reduced cardiovascular events |
Pricing Comparison (Approximate)
| Brand/Generic | Dosage | Price per Unit (USD) |
|---|---|---|
| Effient (Brand) | 10 mg | $8.50 - $10.00 |
| Generic Prasugrel | 10 mg | $4.00 - $6.50 |
| Clopidogrel (Generic) | 75 mg | $1.50 - $3.00 |
Prices may vary by region and pharmacy.
Customer & Physician Reviews
Dr. Alan K., Cardiologist (★★★★★)
“Prasugrel is my go-to for high-risk PCI patients. The rapid onset of action and consistent platelet suppression make it invaluable in preventing stent thrombosis.”
Patient Review (★★★★☆)
“Switched from clopidogrel after a minor heart attack. No issues so far, and my cardiologist says my platelet tests look great!”
Hospital Pharmacist (★★★★★)
“The generic version has made prasugrel more accessible without compromising efficacy. A game-changer in ACS management.”
Conclusion: Why Choose Prasugrel?
Prasugrel stands as a first-line antiplatelet agent for ACS patients undergoing PCI, offering unmatched efficacy in preventing life-threatening thrombotic events. While it carries a slightly higher bleeding risk, proper patient selection and dosing mitigate this concern.
For cardiologists, interventionalists, and pharmacists, prasugrel represents a cost-effective, high-performance alternative to older therapies. Its proven clinical benefits make it a must-have in modern cardiovascular care.
🔹 Order now and enhance your formulary with a superior antiplatelet solution!
This version maintains a medical-expert tone, includes technical details, comparative pricing, and persuasive elements to encourage adoption. Let me know if you’d like any refinements!